Bayer Crop Science Intrinsic Value
Bayer Crop Science (BAYERCROP) median intrinsic value is ₹1511.80 from 10 valuation models (range ₹756–₹4286), vs current price ₹3779.50 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Check Bayer Crop Science networth to track the company's total market size over time.
BAYERCROP Valuation Methods Summary — DCF, Graham Number & P/E
Bayer Crop Science intrinsic value across 10 models vs current price ₹3779.50 — upside/downside and value range per method. For current market price and key ratios, visit Bayer Crop Science share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1954.80 | ₹1563.84 - ₹2345.76 | -48.3% | EPS: ₹162.90, Sector P/E: 12x |
| Book Value Method | asset | ₹755.90 | ₹680.31 - ₹831.49 | -80.0% | Book Value/Share: ₹659.11, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1133.85 | ₹1020.46 - ₹1247.23 | -70.0% | Revenue/Share: ₹1280.22, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1511.80 | ₹1360.62 - ₹1662.98 | -60.0% | EBITDA: ₹1058.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹3256.98 | ₹2605.58 - ₹3908.38 | -13.8% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1133.85 | ₹1020.46 - ₹1247.23 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1319.98 | ₹1187.98 - ₹1451.98 | -65.1% | Revenue Growth: 2.6%, Adj P/E: 8.1x |
| ROE Based Valuation | profitability | ₹2602.67 | ₹2342.40 - ₹2862.94 | -31.1% | ROE: 24.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1318.22 | ₹1186.40 - ₹1450.04 | -65.1% | EPS: ₹162.90, BVPS: ₹659.11 |
| Dividend Yield Method | dividend | ₹4285.71 | ₹3857.14 - ₹4714.28 | +13.4% | DPS: ₹150.00, Target Yield: 3.5% |
BAYERCROP Intrinsic Value vs Market Price — All Valuation Models
Bayer Crop Science fair value range ₹756–₹4286 vs current market price ₹3779.50 across 10 valuation models. See BAYERCROP book value to compare market price against book value per share.
BAYERCROP Intrinsic Value Analysis — Undervalued or Overvalued?
Bayer Crop Science median intrinsic value ₹1511.80, current price ₹3779.50 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of BAYERCROP?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Bayer Crop Science (BAYERCROP) is ₹1511.80 (median value). With the current market price of ₹3779.50, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹755.90 to ₹4285.71, indicating ₹755.90 - ₹4285.71.
Is BAYERCROP undervalued or overvalued?
Based on our multi-method analysis, Bayer Crop Science (BAYERCROP) appears to be trading above calculated value by approximately 60.0%.
BAYERCROP Financial Health — Key Ratios vs Industry Benchmarks
Bayer Crop Science financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 29.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.01x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
BAYERCROP Cash Flow Quality — Operating & Free Cash Flow
Bayer Crop Science operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1,079 Cr | ₹1,079 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹262 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹952 Cr | ₹952 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹609 Cr | ₹609 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹216 Cr | ₹216 Cr | Positive Free Cash Flow | 8/10 |